AC Immune SA (NASDAQ: ACIU) is -40.80% lower on its value in year-to-date trading and has touched a low of $1.78 and a high of $5.14 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ACIU stock was last observed hovering at around $3.03 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $2.96, the stock is -14.40% and -13.10% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.17 million and changing -2.31% at the moment leaves the stock -7.88% off its SMA200. ACIU registered 28.14% gain for a year compared to 6-month gain of -1.33%. The firm has a 50-day simple moving average (SMA 50) of $12.42 and a 200-day simple moving average (SMA200) of -$3.55.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -24.30% loss in the last 1 month and extending the period to 3 months gives it a -40.44%, and is -6.03% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.05% over the week and 9.48% over the month.
AC Immune SA (ACIU) has around 161 employees, a market worth around $293.63M and $16.68M in sales. Profit margin for the company is -360.51%. Distance from 52-week low is 66.29% and -42.41% from its 52-week high. The company has generated returns on investments over the last 12 months (-30.97%).
AC Immune SA quarterly earnings per share for the current quarter are estimated at -$0.11 with sales reaching $8.97M over the same period.The EPS is expected to shrink by -8.19% this year, but quarterly earnings will post -15.40% year-over-year.
51 institutions hold shares in AC Immune SA (ACIU), with institutional investors hold 51.99% of the company’s shares. The shares outstanding are 99.20M, and float is at 57.09M with Short Float at 1.02%. Institutions hold 30.22% of the Float.
The top institutional shareholder in the company is BVF Inc. with over 7.43 million shares valued at $21.95 million. The investor’s holdings represent 8.88% of the ACIU Shares outstanding. As of Jun 29, 2023, the second largest holder is Avidity Partners Management, LP with 2.9 million shares valued at $8.58 million to account for 3.47% of the shares outstanding. The other top investors are Morgan Stanley which holds 1.76 million shares representing 2.10% and valued at over $5.2 million, while Platinum Investment Management Ltd holds 1.58% of the shares totaling 1.32 million with a market value of $3.91 million.
